Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
GLP-1 agonists may be preferable in some elderly patients due to lower hypoglycemia risk, though GI side effects and potential for weight loss (which can be undesirable in frail elderly patients) require careful consideration
They sold 1,000 licenses in the first year
Tirzepatide is an FDA-approved peptide that targets both GLP-1 and GIP receptors to regulate blood sugar, reduce appetite, and control food intake, making it highly effective for weight loss
Diabetologia 66 (10), 18201831
Curr Opin Obstet Gynecol
US$ 23.92
US$ 22.46
US$ 22.01
US$ 27.94
US$ 20.91
